Mutual funds holding Gland Pharma shares
104 mutual fund schemes held Gland Pharma shares in their latest portfolios (October 2026, or September 2026 where a fund house's October 2026 portfolio is not yet in), worth about ₹12,604 cr in all. The largest holders by value are HDFC Mid Cap Fund (1.7% of the fund), Kotak Mid Cap Fund (1.6% of the fund), SBI Large & Midcap Fund (2.5% of the fund).
Against the month before, 3 schemes added Gland Pharma as a new holding and 0 sold out of it completely.
New holders: SBI MNC Fund, PGIM India Midcap Fund, Samco Special Opportunities Fund
By category: Index Fund (32), Sectoral/Thematic (30), Mid Cap (9), Small Cap (8), Multi Cap (7), Large & Mid Cap (6).
9 actively managed schemes holding it are rated A+ or A on their track record, among them SBI Healthcare Opportunities Fund, Axis Multicap Fund, Mirae Asset Healthcare Fund, Aditya Birla Sun Life Small Cap Fund, HDFC Pharma and Healthcare Fund.
Every scheme holding Gland Pharma, by value
| Scheme | Rating | % of fund | Value | Change |
|---|---|---|---|---|
| HDFC Mid Cap FundMid Cap | C | 1.73% | ₹1,742 cr | – |
| Kotak Mid Cap FundMid Cap | C | 1.60% | ₹1,034 cr | – |
| SBI Large & Midcap FundLarge & Mid Cap | C | 2.47% | ₹985 cr | +0.19 |
| Nippon India Growth Mid Cap FundMid Cap | B | 1.77% | ₹866 cr | +0.15 |
| Nippon India Small Cap FundSmall Cap | C | 0.74% | ₹569 cr | +0.08 |
| DSP Small Cap FundSmall Cap | B | 2.01% | ₹407 cr | +0.23 |
| HDFC Large & Mid Cap FundLarge & Mid Cap | B | 1.42% | ₹399 cr | – |
| Mirae Asset Large & Midcap FundLarge & Mid Cap | B | 0.90% | ₹381 cr | -0.25 |
| Nippon India Multi Cap FundMulti Cap | B | 0.70% | ₹367 cr | +0.06 |
| Axis Small Cap FundSmall Cap | B | 1.22% | ₹363 cr | – |
| SBI Contra FundValue / Contra | B | 0.78% | ₹347 cr | +0.06 |
| Nippon India ELSS Tax Saver FundELSS | B | 2.22% | ₹309 cr | +0.16 |
| Mirae Asset Midcap FundMid Cap | B | 1.54% | ₹290 cr | – |
| Canara Robeco Small Cap FundSmall Cap | B | 2.11% | ₹277 cr | -0.21 |
| Axis Midcap FundMid Cap | B | 0.78% | ₹261 cr | – |
| UTI - Flexi Cap Fund.Flexi Cap | B | 1.13% | ₹253 cr | – |
| Nippon India Pharma FundSectoral/Thematic | C | 2.73% | ₹248 cr | +0.20 |
| DSP Healthcare FundSectoral/Thematic | B | 6.61% | ₹246 cr | +0.46 |
| DSP Midcap FundMid Cap | C | 1.16% | ₹219 cr | +0.74 |
| SBI Healthcare Opportunities FundSectoral/Thematic | A | 3.06% | ₹186 cr | +0.10 |
| Mirae Asset Large Cap FundLarge Cap | B | 0.52% | ₹185 cr | – |
| Axis Large & Mid Cap FundLarge & Mid Cap | B | 0.95% | ₹155 cr | – |
| HDFC Multi Cap FundMulti Cap | C | 0.77% | ₹147 cr | – |
| Axis ELSS- Tax Saver FundELSS | B | 0.48% | ₹146 cr | – |
| HDFC Manufacturing FundSectoral/Thematic | – | 1.44% | ₹140 cr | – |
| Axis Multicap FundMulti Cap | A+ | 1.13% | ₹139 cr | – |
| UTI - Mid Cap FundMid Cap | C | 1.19% | ₹138 cr | – |
| Mirae Asset Small Cap FundSmall Cap | – | 1.85% | ₹104 cr | – |
| UTI - MNC FundSectoral/Thematic | B | 4.10% | ₹104 cr | – |
| Mirae Asset Multicap FundMulti Cap | C | 1.99% | ₹104 cr | – |
| Mirae Asset Healthcare FundSectoral/Thematic | A | 2.82% | ₹100 cr | +0.13 |
| Aditya Birla Sun Life MNC FundSectoral/Thematic | C | 3.40% | ₹98 cr | – |
| Aditya Birla Sun Life Small Cap FundSmall Cap | A | 1.47% | ₹86 cr | – |
| SBI MNC FundSectoral/Thematic | B | 1.38% | ₹85 cr | new |
| Mirae Asset ELSS Tax Saver FundELSS | B | 0.30% | ₹73 cr | – |
| DSP Multi Cap FundMulti Cap | – | 2.47% | ₹69 cr | +0.22 |
| WhiteOak Capital Mid Cap FundMid Cap | B | 0.89% | ₹69 cr | – |
| TrustMF Small Cap FundSmall Cap | – | 1.68% | ₹67 cr | – |
| Axis India Manufacturing FundSectoral/Thematic | – | 1.21% | ₹65 cr | – |
| HDFC Pharma and Healthcare FundSectoral/Thematic | A+ | 1.78% | ₹65 cr | – |
And 64 more schemes with smaller holdings.
Value: the scheme's assets under management × the stock's weight, approximate. Change: the weight against the previous month's portfolio, in percentage points; it moves with the share price as well as with buying and selling. Links go to each scheme's Regular plan.
Common questions
How many mutual funds hold Gland Pharma shares?
104 schemes held Gland Pharma in their latest monthly portfolios (October 2026, or September 2026 where a fund house's October 2026 portfolio is not yet in), worth about ₹12,604 cr in all.
Which mutual fund holds the most Gland Pharma shares?
By value, HDFC Mid Cap Fund: about ₹1,742 cr, 1.73% of the fund.
Where does this data come from?
From the monthly portfolios that every fund house must publish by the 10th of the following month. Values are approximate: the fund's assets under management multiplied by the stock's weight in the portfolio.
This page lists which funds hold a stock. It is not a view on the stock or a recommendation to buy or sell it or any fund. Ratings describe past track records, not a forecast.
Send us your CAS and get a written report: which of your funds to keep, which to exit and when, where new SIPs should go, and what each change costs in tax.